SUPN - Supernus Pharmaceuticals Inc (Healthcare: Drug Manufacturers - Specialty & Generic) Projected Earnings Date: 2025-08-05    (Delayed quote data   2025-05-09)
Last
 31.70		 Change
 ⇑ +0.16   (+0.51%)		 Volume
  474,188
Open
 31.54		 High
 32.22		 Low
 31.22
8EMA (Daily)
 31.80		 40EMA (Daily)
 32.21		 50EMA (Daily)
 32.48		 STO (Daily)
 66.969		 MACD Hist (Daily)
 0.078
8EMA (Weekly)
 32.239		 40EMA (Weekly)
 33.33		 50EMA (Weekly)
 33.15		 STO (Weekly)
 19.830		 MACD Hist (Weekly)
 -0.661
Company Profile
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com